A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies 
Tanvi Pednekar 
 - Mumbai  SFIMAR  WIN/2025 
<br/><br/><label>Subjects--Topical Terms: </label><br/>FIN-SPE
<br/><br/><label>Subjects--Facted Index Terms: </label><br/>A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
<br/><br/><label>Dewey Class. No.: </label>WIN/2025/FIN-SPE/PR6728